EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Substrate promiscuity of key resistance P450s confers clothianidin resistance while increasing chlorfenapyr potency in malaria vectors

Magellan Tchouakui, Sulaiman S Ibrahim, Mersimine K Mangoua, Riccado F Thiomela, Tatiane Assatse, Sonia L Ngongang-Yipmo, Abdullahi Muhammad, Leon J M Mugenzi, Benjamin D Menze, Themba Mzilahowa, Charles S Wondji

Cell Reports · 2024-08 · 43 (8) · 114566

DOI: 10.1016/j.celrep.2024.114566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-08. Verfasst von Magellan Tchouakui und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research in Infectious Diseases (CRID), Medical Entomology Department, P.O. Box 13501, Yaoundé, Cameroon. Electronic address: magellan.tch…. Hauptthemen laut MEDLINE: Thiazoles, Guanidines, Insecticide Resistance, Anopheles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Novel insecticides were recently introduced to counter pyrethroid resistance threats in African malaria vectors. To prolong their effectiveness, potential cross-resistance from promiscuous pyrethroid metabolic resistance mechanisms must be elucidated. Here, we demonstrate that the duplicated P450s CYP6P9a/-b, proficient pyrethroid metabolizers, reduce neonicotinoid efficacy in Anopheles funestus while enhancing the potency of chlorfenapyr. Transgenic expression of CYP6P9a/-b in Drosophila confirmed that flies expressing both genes were significantly more resistant to neonicotinoids than controls, whereas the contrasting pattern was observed for chlorfenapyr. This result was also confirmed by RNAi knockdown experiments. In vitro expression of recombinant CYP6P9a and metabolism assays established that it significantly depletes both clothianidin and chlorfenapyr, with metabolism of chlorfenapyr producing the insecticidally active intermediate metabolite tralopyril. This study highlights the risk of cross-resistance between pyrethroid and neonicotinoid and reveals that chlorfenapyr-based control interventions such as Interceptor G2 could remain efficient against some P450-based resistant mosquitoes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiazolesGuanidinesInsecticide ResistanceAnophelesPyrethrinsNeonicotinoidsInsecticidesCytochrome P-450 Enzyme SystemMalariaAnimalsSubstrate SpecificityMosquito VectorsInsect Proteins

Stichwörter der Autor:innen

Anopheles funestusCP: MicrobiologyCYP6P9a and CYP6P9bRNA interferencechlorfenapyrcross-resistanceexperimental hutsinsecticide resistance markersmalariametabolism assayneonicotinoid

Substanzen

clothianidinThiazolesGuanidineschlorfenapyrPyrethrinsNeonicotinoidsInsecticidesCytochrome P-450 Enzyme SystemInsect Proteins

Autor:innen und Institutionen

  • Centre for Research in Infectious Diseases (CRID), Medical Entomology Department, P.O. Box 13501, Yaoundé, Cameroon. Electronic address: magellan.tchouakui@crid-cam.net.
  • Centre for Research in Infectious Diseases (CRID), Medical Entomology Department, P.O. Box 13501, Yaoundé, Cameroon; Department of Biochemistry, Bayero University, PMB 3011, Kano, Nigeria; Department of Vector Biology,…
  • Centre for Research in Infectious Diseases (CRID), Medical Entomology Department, P.O. Box 13501, Yaoundé, Cameroon.
  • Centre for Research in Infectious Diseases (CRID), Medical Entomology Department, P.O. Box 13501, Yaoundé, Cameroon; Parasitology and Ecology Laboratory, Department of Animal Biology and Physiology, Faculty of Science,…
  • Department of Vector Biology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L35QA, UK; Centre for Biotechnology Research, Bayero University, PMB 3011, Kano, Nigeria.
  • Malaria Alert Centre (MAC), Kamuzu University of Health Sciences (KUHeS), Entomology Department, P.O. Box 265, Blantyre, Malawi.

Förderung

  • Wellcome Trust
  • Bill and Melinda Gates Foundation

Zitieren

APA

Tchouakui, M., Ibrahim, S. S., Mangoua, M. K., Thiomela, R. F., Assatse, T., Ngongang-Yipmo, S. L., Muhammad, A., Mugenzi, L. J. M., Menze, B. D., Mzilahowa, T., & Wondji, C. S. (2024). Substrate promiscuity of key resistance P450s confers clothianidin resistance while increasing chlorfenapyr potency in malaria vectors. Cell Reports, 43(8), 114566. https://doi.org/10.1016/j.celrep.2024.114566

Vancouver

Tchouakui M, Ibrahim SS, Mangoua MK, Thiomela RF, Assatse T, Ngongang-Yipmo SL, et al. Substrate promiscuity of key resistance P450s confers clothianidin resistance while increasing chlorfenapyr potency in malaria vectors. Cell Reports. 2024;43(8):114566. doi:10.1016/j.celrep.2024.114566

BibTeX
@article{Tchouakui2024,
  author = {Tchouakui, Magellan and Ibrahim, Sulaiman S and Mangoua, Mersimine K and Thiomela, Riccado F and Assatse, Tatiane and Ngongang-Yipmo, Sonia L and Muhammad, Abdullahi and Mugenzi, Leon J M and Menze, Benjamin D and Mzilahowa, Themba and Wondji, Charles S},
  title = {Substrate promiscuity of key resistance P450s confers clothianidin resistance while increasing chlorfenapyr potency in malaria vectors},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {8},
  pages = {114566},
  doi = {10.1016/j.celrep.2024.114566}
}
Kostenlos starten →